Nitrile Butadiene Rubber (NBR) Latex Market Size Worth US$ 2,860.1 Mn By 2026
/
Date05 Dec 2019
Email Print Friendly Share Acumen Research and Consulting, Recently Published Report On “Nitrile Butadiene Rubber (NBR) Latex Market Size, Share, Growth, Sales and Forecast, 2019... Read More →
Onex Partners and BPEA Announce Secondary Offering of Clarivate Analytics
/
Date05 Dec 2019
Email Print Friendly Share All amounts in U.S. dollars unless otherwise stated TORONTO and HONG KONG, Dec. 04, 2019 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”)... Read More →
Allied Announces December 2019 Distribution and Distribution Increase for 2020
/
Date05 Dec 2019
Email Print Friendly Share TORONTO, Dec. 04, 2019 (GLOBE NEWSWIRE) — Allied Properties REIT (TSX:”AP.UN”) announced today that its Trustees have (i) declared a distribution... Read More →
ZoomerMedia Limited Announces Results for the Year Ended August 31, 2019
/
Date05 Dec 2019
Email Print Friendly Share TORONTO, Dec. 04, 2019 (GLOBE NEWSWIRE) — ZoomerMedia Limited (TSXV:ZUM) (the “Company”), the leader in serving the interests of the 45+... Read More →
TELUS Corporation announces agreement to acquire Competence Call Center through TELUS International
/
Date05 Dec 2019
Email Print Friendly Share Merger adds significant scale to TELUS International, and expands its growing enterprise value to approximately C$5 billion Further growth potential positions... Read More →
Austin Dunham, Founder AD Workout, Develops New Calisthenic Techniques
/
Date05 Dec 2019
Email Print Friendly Share New York, NY, Dec. 04, 2019 (GLOBE NEWSWIRE) — Calisthenics is a form of exercise consisting of a variety of movements... Read More →
Micron Publishes Fiscal 2019 Diversity, Equality and Inclusion Report
/
Date05 Dec 2019
Email Print Friendly Share BOISE, Idaho, Dec. 04, 2019 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), today announced the publication of its second annual... Read More →
Allena Pharmaceuticals Provides Updates on Reloxaliase Development Program and Corporate Activities
/
Date05 Dec 2019
Email Print Friendly Share – Prioritizing Development of Reloxaliase for Patients with Enteric Hyperoxaluria (EH) – – Plan to Re-Engage with U.S. Food and Drug Administration (FDA)... Read More →
GreenVision Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering
/
Date05 Dec 2019
Email Print Friendly Share NEW YORK, Nov. 18, 2019 (GLOBE NEWSWIRE) — GreenVision Acquisition Corp. (NASDAQ: GRNVU, the “Company”) announced today that it priced its... Read More →